Cercare Medical Selected for Nationwide Hospital Rollout in Norway
Advanced Perfusion Imaging Software to Support Stroke and Oncology Diagnostics in Every Public Hospital.
AARHUS, DENMARK / ACCESS Newswire / June 24, 2025 /Cercare Medical is proud to announce its successful selection in the Norwegian National Tender for advanced imaging software. This award secures Cercare Medical 's installation across every public hospital in Norway, enabling national-scale diagnostic excellence in stroke and oncology.
With over 60 installations planned and support for thousands of CT and MRI scans annually, this national rollout marks a major milestone in the adoption of next-generation perfusion imaging. The deployment integrates seamlessly with multiple leading PACS platforms, ensuring clinicians can access Cercare 's biomarkers and maps directly within existing workflows.
In Collaboration with Deepc
To realize this ambitious deployment, Cercare Medical will work closely with its strategic partner Deepc, a German-based AI orchestration platform provider.
Deepc 's role is to ensure centralized AI integration, governance, and monitoringacross all sites. Their platform provides the interoperability and scalability needed to deliver Cercare Medical 's high-performance post-processing tools in a secure and unified environment.
Cercare Medical provides the clinical intelligence layer, with fully automated CT and MRI perfusion post-processing. Its vendor-neutral software supports quantitative biomarkers that enhance decision-making in time-critical cases, including acute ischemic stroke and oncology diagnostics.
Together, the Cercare-Deepc partnership brings national health systems an integrated, intelligent, and compliant AI infrastructure-delivering clinical value without disrupting radiology workflows.
Supporting Better Patient Outcomes Across Norway
Through this initiative, the entire Norwegian population will now benefit from cutting-edge imaging tools designed to improve diagnosis, triage, and treatment planning for both acute and chronic neurological conditions.
"This national rollout is a reflection of the trust placed in our technology and the clinical value it delivers. We are honored to support the Norwegian healthcare system and proud to collaborate with Deepc to make AI-powered imaging more accessible, scalable, and impactful," said Henrik Andersen, Chief Commercial Officerat Cercare Medical.
A Strategic Reference for Global Expansion
The Norwegian deployment marks another significant milestone for Cercare Medical, bringing the company 's global footprint to over 100 installations across 23 countries, supporting more than 1.2 million diagnoses annually. As a national reference site, Norway exemplifies how fully integrated AI and imaging solutions can be deployed at scale-demonstrating Cercare Medical 's ability to combine clinical precision, operational reliability, and health system compliance. This achievement further positions the company for accelerated growth across Europe, Asia, and North America.
###
About Cercare Medical
Cercare Medical is a provider of advanced perfusion imaging solutions. With fully automated, vendor-neutral software for CT and MRI perfusion post-processing, the company supports clinicians across the world with tools that enhance diagnostics for stroke, oncology, Alzheimer 's disease, and other neurological conditions. Cercare 's proprietary biomarkers and automated pipelines enable better imaging maps, improving speed and confidence in clinical decision-making.
For more information, please visitwww.cercare-medical.com or contact:
Martin M. Khan
Senior Director, Marketing
(+45) 5157 3095
mmk@cercare-medical.com
SOURCE: Cercare Medical
View the original press release on ACCESS Newswire
© 2025 ACCESS Newswire. All Rights Reserved.
